Comparing two blood thinners after stroke in atrial fibrillation
Part of Brain & nervous system, Heart & circulation clinical trials.
This study compares two blood thinners, edoxaban and apixaban, to see how they affect new brain lesions seen on MRI in people who have had a stroke and also have atrial fibrillation. It aims to find which might be safer for preventing future brain damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older.
- You had an ischemic stroke (a clot blocking blood flow to the brain) and are now stable for at least 14 days.
- You have been diagnosed with atrial fibrillation (an irregular heart rhythm) confirmed by an ECG or 24-hour heart monitor.
- You have had a brain MRI at the time of your stroke diagnosis.
- You are willing to take part in the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a common blood thinner (apixaban) alone is as safe and effective as combining it with another drug (clopidogrel) to prevent future strokes in people who have both atrial fibrillation and narrowing in the arteries leading to the brain. It aims to find the best way to reduce stroke risk while minimizing bleeding.
This study tests two different blood-thinning medicines to see which is better at preventing another stroke in people who recently had a stroke with no clear cause. The goal is to find a treatment that works well and is safe for you.
This Phase 3 study tests whether a blood thinner (apixaban) can help prevent another stroke and support recovery after you’ve had a brain bleed. You would be assigned to a treatment group, and the study checks safety and whether strokes can be reduced without causing dangerous bleeding.
This Phase 3 trial studies whether it’s safer to avoid long-term blood thinners after a spontaneous brain bleed in people with atrial fibrillation (an irregular heart rhythm). It compares different prevention strategies to lower the risk of stroke or other blood-vessel problems without causing new, serious bleeding.
This trial tests whether starting blood thinners soon after a procedure to remove a blood clot from the brain can safely prevent another stroke in people who have atrial fibrillation. Participation is for those who had a severe stroke, received the clot-removal procedure, and are medically stable afterward.
This trial studies whether closing off part of the heart (the left atrial appendage) can prevent stroke as well as long-term newer blood-thinner pills. It may help people with atrial fibrillation who recently had a stroke or a warning stroke (TIA).
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.